Search

The purpose of this paper is to show directions for promoting alternative modes of transport in Europe and Poland in order to limit the dynamic growth of road transport. The recommendations of the European Commission in relation to the development of intermodal transport are discussed. The structure and size of intermodal transport in Europe are presented. An attempt is made to determine the forecast of intermodal transport in Poland. The basic undertakings determining the development of intermodal transport in Poland are indicated. On the basis of the experience of selected Western European countries, general conclusions regarding the development of intermodal transport in our country are formulated. [ABSTRACT FROM AUTHOR]

Despite the fact that mainstreaming of climate change into existing EU sectoral policies is a key aim, empirical knowledge of how it works in practice remains scarce. With this paper we explore the degree to which climate considerations are taken into account in the implementation of one of the most influential pieces of European water legislation, the Water Framework Directive and, more importantly, we assess possible explanations for the geographical variability in levels of mainstreaming observed. Our empirical research is based on an analysis of both EU and local policy documents, as well as more than forty in-depth interviews, and shows that, for various reasons, the degree of mainstreaming that has taken place differs widely. We conclude that timely incentives and clear guidance will be necessary to ensure progress is made by all, but that a residual fear that the adaptation agenda is open to abuse by those seeking to rationalise failures to fully implement the Water Framework Directive has put a brake on the mainstreaming agenda. [ABSTRACT FROM AUTHOR]

The abstract presents results of the "InterQuality Project - International Research Project on Financing Quality in Healthcare" funded by the 7th Framework Programme (FP7) for Research and Technological Development of the European Union. Grant Agreement No: HEALTH-F3-2010-261369 Objective: To assess reliability, validity and completeness of data on pharmaceutical benefit financing components of health care in United States, United Kingdom, Denmark, Germany, Italy and Poland Theory: Information and guidance used by authorities for decision making in the financing of pharmaceutical care should be reliable, valid and complete. Methods: A systematic review of literature published in the last 10 years, found electronically in Medline, Embase, the Cochrane Library and SCOPUS, supplemented by a manual search, was conducted. Quality of publications was critically appraised using PRISMA [1], MOOSE [2] and STROBE [3] checklists. Contents of found literature were assessed in terms of consistency, coherence and strength. Results: In total, 439 full text publications were included, of which 198 papers were assessed for quality. Of these, 24,6%, 31,2% and 22,1% publications presented high levels of: consistency, coherence and strength, respectively, and 4,3% presented concurrently high levels of all assessed areas. Several areas of weak data availability were identified. Discussion: No comparable analyses were found. Credible data were often unavailable. A questionnaire and a template helpful to collect data where more information is needed were developed, validated and will be sent to experts from InterQuality Consortium countries. Conclusion: To improve the quality of information available to decision makers, so that it is more credible, multiple sources should be used. [ABSTRACT FROM AUTHOR]